These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38007092)

  • 21. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study.
    De Castro N; Neuville S; Sarfati C; Ribaud P; Derouin F; Gluckman E; Socié G; Molina JM
    Bone Marrow Transplant; 2005 Nov; 36(10):879-83. PubMed ID: 16151423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cytology and polymerase chain reaction based detection of Pneumocystis jirovecii infection in bronchoalveolar lavage fluid.
    Gupta R; Iyer VK; Mirdha BR; Guleria R; Kumar L; Agarwal SK
    Acta Cytol; 2010; 54(3):296-302. PubMed ID: 20518414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumocystis pneumonia in South African children diagnosed by molecular methods.
    Morrow BM; Samuel CM; Zampoli M; Whitelaw A; Zar HJ
    BMC Res Notes; 2014 Jan; 7():26. PubMed ID: 24410938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
    Sarwar S; Carey B; Hegarty JE; McCormick PA
    Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.
    Souza JP; Boeckh M; Gooley TA; Flowers ME; Crawford SW
    Clin Infect Dis; 1999 Dec; 29(6):1467-71. PubMed ID: 10585797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.
    Williams KM; Ahn KW; Chen M; Aljurf MD; Agwu AL; Chen AR; Walsh TJ; Szabolcs P; Boeckh MJ; Auletta JJ; Lindemans CA; Zanis-Neto J; Malvezzi M; Lister J; de Toledo Codina JS; Sackey K; Chakrabarty JL; Ljungman P; Wingard JR; Seftel MD; Seo S; Hale GA; Wirk B; Smith MS; Savani BN; Lazarus HM; Marks DI; Ustun C; Abdel-Azim H; Dvorak CC; Szer J; Storek J; Yong A; Riches MR
    Bone Marrow Transplant; 2016 Apr; 51(4):573-80. PubMed ID: 26726945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumocystis jirovecii pneumonia in kidney transplantation.
    Goto N; Oka S
    Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
    Averbuch D; De Greef J; Duréault A; Wendel L; Tridello G; Lebeaux D; Mikulska M; Gil L; Knelange N; Zuckerman T; Roussel X; Robin C; Xhaard A; Aljurf M; Beguin Y; Le Bourgeois A; Botella-Garcia C; Khanna N; Van Praet J; Kröger N; Blijlevens N; Ducastelle Leprêtre S; Ho A; Roos-Weil D; Yeshurun M; Lortholary O; Fontanet A; de la Camara R; Coussement J; Maertens J; Styczynski J;
    Clin Infect Dis; 2022 Aug; 75(1):88-97. PubMed ID: 34596213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Dufresne SF; Boucher A; Jevnikar A; Prasad GVR; Shoker A; Kabbani D; Hebert MJ; Cardinal H; Houde I; Humar A; Kumar D
    Clin Infect Dis; 2019 Apr; 68(8):1320-1326. PubMed ID: 30107568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Giebel S; Labopin M; Houhou M; Caillot D; Finke J; Blaise D; Fegueux N; Ethell M; Cornelissen JJ; Forcade E; Yakoub-Agha I; Lussana F; Maertens J; Bourhis JH; Jindra P; Gorin NC; Nagler A; Mohty M
    Bone Marrow Transplant; 2023 Apr; 58(4):393-400. PubMed ID: 36611097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumocystis jirovecii pneumonia in renal transplant recipients occurring after discontinuation of prophylaxis: a case–control study.
    De Castro N; Xu F; Porcher R; Pavie J; Molina JM; Peraldi MN
    Clin Microbiol Infect; 2010 Sep; 16(9):1375-7. PubMed ID: 20041898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
    Afrough A; Alsfeld LC; Milton DR; Delgado R; Popat UR; Nieto Y; Kebriaei P; Oran B; Saini N; Srour S; Hosing C; Cheema FH; Ahmed S; Manasanch EE; Lee HC; Kaufman GP; Patel KK; Weber DM; Orlowski RZ; Pinnix CC; Dabaja BS; Thomas SK; Champlin RE; Shpall EJ; Qazilbash MH; Bashir Q
    Transplant Cell Ther; 2023 Apr; 29(4):264.e1-264.e9. PubMed ID: 35605883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.
    Iriart X; Challan Belval T; Fillaux J; Esposito L; Lavergne RA; Cardeau-Desangles I; Roques O; Del Bello A; Cointault O; Lavayssière L; Chauvin P; Menard S; Magnaval JF; Cassaing S; Rostaing L; Kamar N; Berry A
    Am J Transplant; 2015 Jan; 15(1):190-9. PubMed ID: 25496195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of Pneumocystis jirovecii Plasma Cell-Free DNA PCR for Noninvasive Diagnosis of Pneumocystis Pneumonia.
    Moreno A; Epstein D; Budvytiene I; Banaei N
    J Clin Microbiol; 2022 May; 60(5):e0010122. PubMed ID: 35387472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of nested polymerase chain reaction and immunofluorescence for detection of Pneumocystis carinii pneumonia.
    Olsson M; Strålin K; Holmberg H
    Clin Microbiol Infect; 2001 Sep; 7(9):492-7. PubMed ID: 11678932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
    Fulcher J; Blanchard AP; Bredeson C; van Walraven C
    Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
    Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
    Transplant Cell Ther; 2022 Jun; 28(6):335.e1-335.e17. PubMed ID: 34757220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.